Zobrazeno 1 - 10
of 165
pro vyhledávání: '"Veronique, Leblond"'
Autor:
Caroline Dartigeas, Borhane Slama, Margaret Doyle, Christoph Tapprich, Claire Albrecht, Sandrine Dupuis, Robert Wapenaar, Charlotte Schmidt-Hieber, Veronique Leblond
Publikováno v:
Clinical Hematology International, Vol 4, Iss 3, Pp 65-74 (2022)
Abstract The FIRE study investigated the real-world effectiveness and safety of ibrutinib in prospectively observed patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) and mantle cell lymphoma (MCL) in France. Patients w
Externí odkaz:
https://doaj.org/article/a1c7626872d6438d82dd956185a4915a
Autor:
Irene Defrancesco, Virginia Valeria Ferretti, Pierre Morel, Charalampia Kyriakou, Efstathios Kastritis, Ibrahim Tohidi-Esfahani, Alessandra Tedeschi, Christian Buske, Ramón García-Sanz, Josephine M.I. Vos, Veronica Peri, Gloria Margiotta Casaluci, Angela Ferrari, Francesco Piazza, Rimke Oostvogels, Ester Lovato, Lydia Montes, Luc Matthieu Fornecker, Alexander Grunenberg, Meletios Athanasios Dimopoulos, Constantine S. Tam, Shirley D’Sa, Veronique Leblond, Judith Trotman, Francesco Passamonti, Luca Arcaini, Marzia Varettoni, on behalf of the European Consortium for Waldenström’s Macroglobulinemia
Publikováno v:
HemaSphere, Vol 7, Iss 6, p e887 (2023)
Externí odkaz:
https://doaj.org/article/281cb2ec8c4e4ac299998c7e4269a8d8
Autor:
Nathalie Forgeard, Marine Baron, Jonathan Caron, Clementine Boccon-Gibod, Daphne Krzisch, Nayara Guedes, Veronique Morel, Nathalie Jacque, Maya Ouzegdouh, Sylvain Choquet, Clotilde Bravetti, Florence Nguyen-Khac, Elise Chapiro, Veronique Leblond, Damien Roos-Weil
Publikováno v:
Haematologica, Vol 107, Iss 11 (2022)
Externí odkaz:
https://doaj.org/article/8e39d02f05074da4ab905ed5259c5b64
Autor:
Fotini Kostopoulou, Clementine Gabillaud, Elise Chapiro, Beatrice Grange, Julie Tran, Simon Bouzy, Michael Degaud, Hussein Ghamlouch, Magali Le Garff‐Tavernier, Karim Maloum, Sylvain Choquet, Veronique Leblond, Jean Gabarre, Anne Lavaud, Veronique Morel, Damien Roos‐Weil, Madalina Uzunov, Romain Guieze, Olivier A. Bernard, Santos A. Susin, Olivier Tournilhac, Florence Nguyen‐Khac, the French Innovative Leukemia Organization (FILO) group
Publikováno v:
Cancer Medicine, Vol 8, Iss 6, Pp 3131-3141 (2019)
Abstract The different types of drug resistance encountered in chronic lymphocytic leukemia (CLL) cannot be fully accounted for by the 17p deletion (and/or TP53 mutation), a complex karyotype (CK), immunoglobulin heavy‐chain variable region genes (
Externí odkaz:
https://doaj.org/article/7d10de105bfe4bc180f4ac188592025d
Autor:
Christian Buske, Meletios A. Dimopoulos, Alexander Grunenberg, Efstathios Kastritis, Cecile Tomowiak, Béatrice Mahé, Xavier Troussard, Roman Hajek, Andreas Viardot, Olivier Tournilhac, Therese Aurran, Stephane Lepretre, Hacene Zerazhi, Benedicte Hivert, Veronique Leblond, Sophie de Guibert, Lena Brandefors, Ramon Garcia-Sanz, Maria Gomes da Silva, Eva Kimby, Birgit Schmelzle, Dajana Kaszynski, Jens Dreyhaupt, Rainer Muche, Pierre Morel
Publikováno v:
Journal of Clinical Oncology. 41:2607-2616
PURPOSE Rituximab/chemotherapy is a cornerstone of treatment for Waldenström's macroglobulinemia (WM). In addition, bortezomib has shown significant activity in WM. This study evaluated the efficacy and safety of dexamethasone, rituximab, and cyclop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf5f8352d02c1f04ec733619631efef3
https://doi.org/10.1200/jco.22.01805
https://doi.org/10.1200/jco.22.01805
Autor:
Christian Buske, Alessandra Tedeschi, Judith Trotman, Ramón García-Sanz, David MacDonald, Veronique Leblond, Beatrice Mahe, Charles Herbaux, Jeffrey V Matous, Constantine S Tam, Leonard T Heffner, Marzia Varettoni, M Lia Palomba, Chaim Shustik, Efstathios Kastritis, Steven P Treon, Jerry Ping, Bernhard Hauns, Israel Arango-Hisijara, Meletios A Dimopoulos
Publikováno v:
Future Oncology. 19:345-353
What is this summary about? This article provides a short summary of 5-year results from the iNNOVATE trial. The original paper was published in the Journal of Clinical Oncology in October 2021. People with Waldenström's macroglobulinemia (WM) were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7a87fd4226e2f3a93d1888be51c70e0
https://doi.org/10.2217/fon-2022-1015
https://doi.org/10.2217/fon-2022-1015
Autor:
Dipti Talaulikar, Ranjana H. Advani, Andrew R. Branagan, Christian Buske, Meletios A. Dimopoulos, Shirley D'Sa, Maria J. Kersten, Veronique Leblond, Monique C. Minnema, Roger G. Owen, Maria Lia Palomba, Alessandra Tedeschi, Judith Trotman, Marzia Varettoni, Josephine M. Vos, Steven P. Treon, Efstathios Kastritis, Jorge J. Castillo
Publikováno v:
HemaSphere, Vol 4, Iss 4, p e433 (2020)
Abstract. In the light of the COVID-19 pandemic, the International Workshop on Waldenström Macroglobulinemia (IWWM) Treatment Recommendations Panel felt the need to provide a consensus statement for the management of Waldenström Macroglobulinemia (
Externí odkaz:
https://doaj.org/article/e598de380c454ba7b52fd83db2f1a95e
Autor:
Jennifer Edelmann, Karlheinz Holzmann, Eugen Tausch, Emily A. Saunderson, Billy M. C. Jebaraj, Daniela Steinbrecher, Anna Dolnik, Tamara J. Blätte, Dan A. Landau, Jenny Saub, Sven Estenfelder, Stefan Ibach, Florence Cymbalista, Veronique Leblond, Alain Delmer, Jasmin Bahlo, Sandra Robrecht, Kirsten Fischer, Valentin Goede, Lars Bullinger, Catherine J. Wu, Daniel Mertens, Gabriella Ficz, John G. Gribben, Michael Hallek, Hartmut Döhner, Stephan Stilgenbauer
Publikováno v:
Haematologica, Vol 105, Iss 5 (2020)
To identify genomic alterations contributing to the pathogenesis of high-risk chronic lymphocytic leukemia (CLL) beyond the well-established role of TP53 aberrations, we comprehensively analyzed 75 relapsed/refractory and 71 treatment-naïve high-ris
Externí odkaz:
https://doaj.org/article/b6616ac47caa446b810bf72999b7a258
Autor:
Anne-Sophie Michallet, Rémi Letestu, Magali Le Garff-Tavernier, Lydia Campos, Michel Ticchioni, Marie-Sarah Dilhuydy, Stephane MORISSET, Valerie Rouille, Beatrice Mahe, Kamel Laribi, Bruno Villemagne, Emmanuelle France Ferrant, Olivier Tournilhac, Alain Jacques Delmer, Lysiane Molina, Veronique Leblond, Cécile TOMOWIAK, Sophie De Guibert, Frederique Orsini Piocelle, Anne Banos, Philippe Carassou, Guillaume Cartron, Luc-Matthieu Fornecker, Loïc Ysebaert, Caroline Dartigeas, Malgorzata Truchan-Graczyk, Jean-Pierre Vilque, Thérèse Aurran Schleinitz, Florence Cymbalista, Stéphane Leprêtre, Vincent Lévy, Florence Nguyen-Khac, Pierre Feugier
Publikováno v:
Blood Advances.
In previously untreated, medically fit patients with chronic lymphocytic leukemia, research is focused on developing fixed-duration strategies to improve long-term outcomes whilst sparing patients from serious toxicities. The ICLL-07 trial evaluated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8291053de23de4e66ca99d7c20098031
https://doi.org/10.1182/bloodadvances.2022009594
https://doi.org/10.1182/bloodadvances.2022009594
Autor:
Christian Buske, Jorge J. Castillo, Jithma Prasad Abeykoon, Ranjana Advani, Suzanne O. Arulogun, Andrew R. Branagan, Xinxin Cao, Shirley D'Sa, Jian Hou, Prashant Kapoor, Efstathios Kastritis, Marie J. Kersten, Veronique LeBlond, Merav Leiba, Jeffrey V. Matous, Jonas Paludo, Lugui Qiu, Constantine S. Tam, Alessandra Tedeschi, Sheeba K. Thomas, Ibrahim Tohidi-Esfahani, Marzia Varettoni, Josephine M. Vos, Ramon Garcia-Sanz, Jesus San-Miguel, Meletios A. Dimopoulos, Steven P. Treon, Judith Trotman
Publikováno v:
Seminars in Hematology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc2c5943f3ea7460e36898a4895528c9
https://doi.org/10.1053/j.seminhematol.2023.03.005
https://doi.org/10.1053/j.seminhematol.2023.03.005